Treatment of the elderly patient with acute myeloid leukaemia.

  title={Treatment of the elderly patient with acute myeloid leukaemia.},
  author={Bob L{\"o}wenberg},
  journal={Bailliere's clinical haematology},
  volume={9 1},
Individuals of 60 years living in western countries generally have a mean life expectancy of 20 years at least. Therefore, when aged individuals present with AML, it is a necessity and a challenge to treat them as efficiently as possible. AML is mainly a disease of the elderly and accounts for more than 50% of its incidence among the general population. The treatment of older individuals with AML has remained difficult and its success is still limited. While in adults with AML of less than 60… CONTINUE READING